http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 29 Jul 2026 11:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jul+29/26832729.html si-local-file:///var/storage/secattach/20260729/26832729.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jul+29/26832729.html Wed, 29 Jul 2026 11:00:00 -0400 ALVO O.73793734 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jul+29/26832729.html si-local-file:///var/storage/secattach/20260729/26832729.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jul+29/26832729.html Wed, 29 Jul 2026 11:00:00 -0400 ALVO O.73793734 http://www.streetinsider.com/Corporate+News/FDA+closes+inspection+of+Alvotech%27s+Iceland+facility+with+VAI+rating/26831871.html <p>Alvotech (NASDAQ: ALVO) announced that the U.S. Food and Drug Administration has closed its inspection of the company's manufacturing facility in Reykjavik, Iceland, with a classification of Voluntary Action Indicated (VAI). The inspection was conducted in May 2026.</p><p>A VAI classification indicates that the FDA found objectionable conditions or practices, but the agency is not prepared to take or recommend any administrative or regulatory action.</p><p>"This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing operations," said Lisa Graver, CEO of Alvotech. "We continue to work with the http://www.streetinsider.com/Corporate+News/FDA+closes+inspection+of+Alvotech%27s+Iceland+facility+with+VAI+rating/26831871.html Wed, 29 Jul 2026 09:26:28 -0400 ALVO http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Press+Releases/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html <p align="left">REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has closed its inspection of the company’s manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).</p> <p>“This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing http://www.streetinsider.com/Globe+Newswire/Alvotech+announces+successful+closure+of+FDA+inspection+of+manufacturing+facility/26831869.html Wed, 29 Jul 2026 09:25:00 -0400 A.06822034 ALVO ALVO-SDB ALVO-SDB.S ALVO.SDB ALVO.SDB.S O.20026344 O.73793734 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jul+01/26717086.html si-local-file:///var/storage/secattach/20260701/26717086.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jul+01/26717086.html Wed, 01 Jul 2026 08:00:00 -0400 ALVO O.73793734 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jul+01/26717086.html si-local-file:///var/storage/secattach/20260701/26717086.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jul+01/26717086.html Wed, 01 Jul 2026 08:00:00 -0400 ALVO O.73793734 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Alvotech+++++++++++++++++++++++++++++++Filed+by%3A+Celtic+Holdings+SCA/26715241.html si-local-file:///var/storage/secattach/20260630/26715241.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Alvotech+++++++++++++++++++++++++++++++Filed+by%3A+Celtic+Holdings+SCA/26715241.html Tue, 30 Jun 2026 20:09:00 -0400 ALVO O.73793734 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Alvotech+++++++++++++++++++++++++++++++Filed+by%3A+Celtic+Holdings+SCA/26715241.html si-local-file:///var/storage/secattach/20260630/26715241.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Alvotech+++++++++++++++++++++++++++++++Filed+by%3A+Celtic+Holdings+SCA/26715241.html Tue, 30 Jun 2026 20:09:00 -0400 ALVO O.73793734 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jun+18/26664837.html si-local-file:///var/storage/secattach/20260618/26664837.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jun+18/26664837.html Thu, 18 Jun 2026 12:33:00 -0400 ALVO O.73793734 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jun+18/26664837.html si-local-file:///var/storage/secattach/20260618/26664837.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Alvotech++++++++++++++++++For%3A+Jun+18/26664837.html Thu, 18 Jun 2026 12:33:00 -0400 ALVO O.73793734